Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshad Moradi

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
The Journal of Thoracic and Cardiovascular Surgery|May 14, 2022
Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphomaCatherine T Byrd, Winston L Trope, Prasha Bhandari, et al.
Molecular Imaging and Biology|August 14, 2020
Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[<sup>18</sup>F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with ImmunotherapyRyusuke Nakamoto, Lisa C Zaba, Jarrett Rosenberg, et al.
JTO Clinical and Research Reports|November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed <i>EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab TherapyJacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2024
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [<sup>177</sup>Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancerHong Song, Maria Isabel Leonio, Valentina Ferri, et al.
ACS Chemical Neuroscience|June 13, 2023
Clinical Radiosynthesis and Translation of [<sup>18</sup>F]OP-801: A Novel Radiotracer for Imaging Reactive Microglia and MacrophagesIsaac M Jackson, Mackenzie L Carlson, Corinne Beinat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 2022
Correlation of <sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate CancerHeying Duan, Lucia Baratto, Richard E Fan, et al.
Head & Neck|August 3, 2022
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinomaJacob A Miller, Farshad Moradi, Vandana Sundaram, et al.
Cancers|December 17, 2024
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [<sup>68</sup>Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as ReferenceSamuele Ghezzo, Praveen Gurunath Bharathi, Heying Duan, et al.
AJNR. American Journal of Neuroradiology|August 8, 2025
ASNR Consensus Statement: Integrating Neuro-PET Interpretation into Neuroradiology Training and PracticeJana Ivanidze, Ana M Franceschi, Max Wintermark, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
The Journal of Thoracic and Cardiovascular Surgery|May 14, 2022
Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphomaCatherine T Byrd, Winston L Trope, Prasha Bhandari, et al.
Molecular Imaging and Biology|August 14, 2020
Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[<sup>18</sup>F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with ImmunotherapyRyusuke Nakamoto, Lisa C Zaba, Jarrett Rosenberg, et al.
JTO Clinical and Research Reports|November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed <i>EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab TherapyJacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2024
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [<sup>177</sup>Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancerHong Song, Maria Isabel Leonio, Valentina Ferri, et al.
ACS Chemical Neuroscience|June 13, 2023
Clinical Radiosynthesis and Translation of [<sup>18</sup>F]OP-801: A Novel Radiotracer for Imaging Reactive Microglia and MacrophagesIsaac M Jackson, Mackenzie L Carlson, Corinne Beinat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 13, 2022
Correlation of <sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate CancerHeying Duan, Lucia Baratto, Richard E Fan, et al.
Head & Neck|August 3, 2022
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinomaJacob A Miller, Farshad Moradi, Vandana Sundaram, et al.
Cancers|December 17, 2024
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [<sup>68</sup>Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as ReferenceSamuele Ghezzo, Praveen Gurunath Bharathi, Heying Duan, et al.
AJNR. American Journal of Neuroradiology|August 8, 2025
ASNR Consensus Statement: Integrating Neuro-PET Interpretation into Neuroradiology Training and PracticeJana Ivanidze, Ana M Franceschi, Max Wintermark, et al.
Pageof 12